Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 016042

Expand all

DYAZIDE (HYDROCHLOROTHIAZIDE; TRIAMTERENE)
25MG;37.5MG
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; TRIAMTERENE
Proprietary Name: DYAZIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG;37.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N016042
Product Number: 003
Approval Date: Mar 3, 1994
Applicant Holder Full Name: GLAXOSMITHKLINE LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
DYAZIDE (HYDROCHLOROTHIAZIDE; TRIAMTERENE)
25MG;50MG
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; TRIAMTERENE
Proprietary Name: DYAZIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG;50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N016042
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English